Brokers Set Expectations for Larimar Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:LRMR)
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Research analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Larimar Therapeutics in a report released on Thursday, October 3rd. Wedbush analyst L. Chico anticipates that the company will post earnings of ($0.33) per share for the quarter. Wedbush currently has a […]
9 Oct 05:58 · The Markets Daily